Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 84.17 K181.14 K305.73 K498.77 K412.67 K374.53 K 1.59 M Research & development —————— — Operating income -84.17 K-181.14 K-305.73 K-498.77 K-412.67 K-374.53 K -1.59 M Non-Operating Income, Total 113.67 K1.5 M1.51 M1.42 M1.3 M1.32 M 5.56 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 113.67 K1.5 M1.51 M1.42 M1.3 M1.32 M 5.56 M Unusual income/expense —————— — Pretax income 29.5 K1.32 M1.2 M925.42 K891.6 K944.15 K 3.96 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 29.5 K1.32 M1.2 M925.42 K891.6 K944.15 K 3.96 M Discontinued operations —————— — Net income 29.5 K1.32 M1.2 M925.42 K891.6 K944.15 K 3.96 M Dilution adjustment 10.72 M1.5 M1.51 M1.42 M1.3 M1.32 M 5.56 M Preferred dividends 10.72 M1.5 M1.51 M1.42 M1.3 M1.32 M 5.56 M Diluted net income available to common stockholders 29.5 K1.32 M1.2 M925.42 K891.6 K944.15 K 3.96 M Basic earnings per share (Basic EPS) 0.080.120.120.280.080.1 0.58 Diluted earnings per share (Diluted EPS) 0.080.120.120.280.080.1 0.58 Average basic shares outstanding 6.27 M13.4 M15.78 M28.54 M20.45 M20.45 M — Diluted shares outstanding 12.36 M19.2 M21.48 M28.68 M20.45 M20.45 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —